WP Sheridan

643 total citations
11 papers, 518 citations indexed

About

WP Sheridan is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, WP Sheridan has authored 11 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in WP Sheridan's work include Hematopoietic Stem Cell Transplantation (5 papers), Acute Myeloid Leukemia Research (3 papers) and Neutropenia and Cancer Infections (3 papers). WP Sheridan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Acute Myeloid Leukemia Research (3 papers) and Neutropenia and Cancer Infections (3 papers). WP Sheridan collaborates with scholars based in Australia and United States. WP Sheridan's co-authors include George Morstyn, JE Layton, Jeff Szer, Phillips Gl, C. Glenn Begley, Jonathan Cebon, J E Tarpley, Terence L. Kirley, Shuangyi Yin and Esther Choi and has published in prestigious journals such as Blood, British Journal of Cancer and PubMed.

In The Last Decade

WP Sheridan

11 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
WP Sheridan Australia 8 347 203 129 119 94 11 518
Masuji Yamamoto Japan 9 373 1.1× 239 1.2× 88 0.7× 162 1.4× 72 0.8× 19 574
K Hirashima Japan 12 295 0.9× 134 0.7× 78 0.6× 78 0.7× 99 1.1× 44 465
Liliane Dal Cortivo France 11 396 1.1× 176 0.9× 124 1.0× 326 2.7× 100 1.1× 19 670
Christina Gasparetto United States 11 291 0.8× 157 0.8× 38 0.3× 124 1.0× 75 0.8× 16 456
R S Stein United States 9 341 1.0× 196 1.0× 62 0.5× 44 0.4× 226 2.4× 9 624
D G Nathan United States 10 249 0.7× 75 0.4× 84 0.7× 138 1.2× 118 1.3× 17 505
Giuseppe Console Italy 15 475 1.4× 302 1.5× 64 0.5× 90 0.8× 87 0.9× 51 633
HM Goselink Netherlands 6 239 0.7× 99 0.5× 52 0.4× 246 2.1× 41 0.4× 9 418
BS Andersson United States 9 379 1.1× 240 1.2× 46 0.4× 162 1.4× 95 1.0× 10 615
EM Bryant United States 11 435 1.3× 144 0.7× 83 0.6× 234 2.0× 118 1.3× 16 675

Countries citing papers authored by WP Sheridan

Since Specialization
Citations

This map shows the geographic impact of WP Sheridan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WP Sheridan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WP Sheridan more than expected).

Fields of papers citing papers by WP Sheridan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by WP Sheridan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WP Sheridan. The network helps show where WP Sheridan may publish in the future.

Co-authorship network of co-authors of WP Sheridan

This figure shows the co-authorship network connecting the top 25 collaborators of WP Sheridan. A scholar is included among the top collaborators of WP Sheridan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with WP Sheridan. WP Sheridan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ulich, TR, Giorgio Senaldi, Olaf Kinstler, et al.. (1996). Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice. Blood. 87(12). 5006–5015. 91 indexed citations
2.
Wiley, James S., et al.. (1994). Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter.. PubMed. 8(1). 181–5. 23 indexed citations
3.
Löwenberg, Bob, DC Dale, & WP Sheridan. (1994). Clinical use of hematopoietic growth factors.. PubMed. Suppl. 33–40. 1 indexed citations
4.
Sheridan, WP, To Lb, A. Grigg, et al.. (1994). Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies.. PubMed. 14(1). 105–11. 62 indexed citations
5.
Szer, Jeff, et al.. (1993). Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT.. PubMed. 11(2). 109–11. 69 indexed citations
6.
Wiley, James S., Jonathan Cebon, Jeff Szer, et al.. (1993). Cytokine priming of acute myeloid leukemia may produce a pulmonary syndrome when associated with a rapid increase in peripheral blood myeloblasts [letter]. Blood. 82(11). 3511–3512. 10 indexed citations
7.
Sheridan, WP, et al.. (1992). Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. British Journal of Cancer. 66(5). 893–899. 63 indexed citations
8.
Morstyn, George & WP Sheridan. (1991). The role of colony stimulating factors in cancer therapy.. PubMed. 12. 307–26. 2 indexed citations
10.
11.
Sheridan, WP, et al.. (1989). Hashimoto's disease, thyroid lymphoma and splenic atrophy.. PubMed. 1(1). 51–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026